Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc
(NY:
CYBN
)
0.2550
-0.0012 (-0.47%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
37
38
Next >
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been...
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
March 06, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 03, 2023
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Joins Chopra Foundation Founder, Other Experts in Psychedelics Discussions
March 03, 2023
Via
Investor Brand Network
Cybin Inc. Was Down 70% In 2022 But Has Bounced Back By 59% YTD - Here's Why
March 03, 2023
A review of Cybin Inc.'s latest quarterly financials, the history of its stock price performance, and the price forecasts for the stock over the next 12 months.
Via
Talk Markets
Cybin: Positive Clinical Trial On Psilocybin Analog For Major Depression & Updates On DMT Analog Program
March 02, 2023
Psychedelics biotech company Cybin Inc.
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
March 02, 2023
Via
Benzinga
Cybin and The Chopra Foundation to Participate in Featured Session at Upcoming 2023 South by Southwest® Conference
March 02, 2023
From
Cybin Inc.
Via
Business Wire
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 01, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
February 28, 2023
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Progress Updates on Two Clinical Development Programs
February 28, 2023
Via
Investor Brand Network
Cybin Announces Positive Data from its CYB003 Phase 1/2a Trial and Provides Update on its CYB004 Development Program
February 28, 2023
From
Cybin Inc.
Via
Business Wire
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and...
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 27, 2023
February 27, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio By 2-To-1 Margin YTD
February 26, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some will bounce back with
Via
Talk Markets
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
February 26, 2023
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage...
Via
Talk Markets
Only 2 Of 5 Cannabis Categories Have Advanced YTD
February 25, 2023
The 5 categories in the cannabis sector perform quite differently from each other but YTD the common trend is mostly downward.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
February 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
February 23, 2023
Via
Benzinga
Cybin Stock Down On Laying Off 15% Of Workforce As Part Of A Streamlining Clinical Alignment
February 23, 2023
Cybin Inc. (NEO:CYBN) (AMEX:CYBN) announced Thursday a streamlining plan aimed at maximizing the company’s operating efficiency and allowing it to focus on critical clinical trials.
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Plan to Streamline Efforts, Maximize Efficiency, Focus on Clinical Trials
February 23, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Psychedelic Stock Gainers And Losers From February 22, 2023
February 22, 2023
Via
Benzinga
Cybin Announces Streamlined Clinical Alignment
February 22, 2023
From
Cybin Inc.
Via
Business Wire
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and...
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
February 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
February 20, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin
February 19, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with
Via
Talk Markets
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
February 17, 2023
A look at the performance of the six largest psychedelic stocks by market capitalization.
Via
Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
February 17, 2023
Via
Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
February 16, 2023
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.